Qube Research & Technologies (QRT)’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.95M Buy
136,783
+124,025
+972% +$9.37M 0.01% 1509
2026
Q2
$933K Buy
+12,758
New +$877K ﹤0.01% 2436
2024
Q2
– Sell
-74,777
Closed -$4.66M – 4268
2024
Q1
$4.66M Buy
74,777
+24,066
+47% +$1.56M 0.01% 1275
2023
Q4
$2.93M Buy
+50,711
New +$2.6M 0.01% 1334
2022
Q4
– Sell
-549
Closed -$27K – 2732
2022
Q3
$27K Sell
549
-71
-11% -$3.35K ﹤0.01% 2254
2022
Q2
$31K Buy
+620
New +$27.4K ﹤0.01% 2204

Other funds holding IRON

Qube Research & Technologies (QRT)'s IRON Position: Q3 2026 in Review

Qube Research & Technologies (QRT) increased its Disc Medicine (IRON) stake by 972% in Q3 2026, buying an estimated $9.37M and bringing the position to 136,783 shares worth $8.95M. The position accounts for 0.01% of the portfolio, ranked #1509.

Qube Research & Technologies (QRT) first reported a position in IRON in Q2 2022 and has held it in 6 quarters since. 150 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

  • Qube Research & Technologies (QRT) held 136,783 shares of Disc Medicine worth $8.95M as of Q3 2026.
  • Qube Research & Technologies (QRT) bought 124,025 Disc Medicine shares in Q3 2026, an estimated $9.37M.
  • Disc Medicine made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1509 holding.
  • Qube Research & Technologies (QRT) first reported a position in Disc Medicine in Q2 2022 and has held it in 6 quarters since.
  • 150 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.